CIK 0001434647 · Non-accelerated filer<br>Smaller reporting company
ZEVRA THERAPEUTICS, INC.
Sign in to watch- Ticker
- ZVRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 205894398
- Phone
- (888) 958-1253
- Business address
- 101 FEDERAL STREET, BOSTON, MA, 02110
- Former names
- KEMPHARM, INC, KEMPHARM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $224,948
- in 1 filing, $225K under 10b5-1 plans
Net −$224,948. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-31 | Guenther Sven Chief Scientific Officer | Grant or award · Restricted Stock Unit | +79,000 | 79,000 | ||
| 2024-01-31 | Clifton R. LaDuane CFO, Secretary & Treasurer | Grant or award · Restricted Stock Unit | +130,000 | 130,000 | ||
| 2024-01-31 | McFarlane Neil F. President and CEO | Grant or award · Restricted Stock Unit | +700,000 | 700,000 | ||
| 2024-01-20 | Shih Alvin Director | Grant or award · Stock Option (right to buy) | +58,800 | 58,800 | ||
| 2023-10-10 | McFarlane Neil F. President and CEO | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2023-10-10 | McFarlane Neil F. President and CEO | Grant or award · Restricted Stock Unit | +200,000 | 200,000 | ||
| 2023-09-06 | Clifton R. LaDuane CFO, Secretary & Treasurer | Purchase | +1,000 | $4.96 | $5K | 15,309 |
| 2023-09-06 | Anderson Thomas Director | Purchase | +10,000 | $4.88 | $49K | 10,000 |
| 2023-09-05 | Schafer Joshua CCO & EVP, Bus. Development | Purchase | +500 | $5.13 | $3K | 3,500 |
| 2023-09-05 | Bode John B Director | Purchase | +10,000 | $5.13 | $51K | 20,000 |
| 2023-08-07 | Anderson Thomas Director | Grant or award · Stock Option (right to buy) | +58,800 | 58,800 | ||
| 2023-06-23 | Watton Corey Michael Director | Purchase | +275 | $5.95 | $2K | 1,000 |
| 2023-06-09 | Watton Corey Michael Director | Purchase | +325 | $5.52 | $2K | 725 |
| 2023-05-31 | FAVORITO TAMARA A Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2023-05-30 | Watton Corey Michael Director | Purchase | +400 | $5.11 | $2K | 400 |
| 2023-05-19 | Schafer Joshua CCO & EVP, Bus. Development | Purchase | +1,000 | $5.42 | $5K | 3,000 |
| 2023-05-18 | Bode John B Director | Purchase | +1,390 | $5.04 | $7K | 1,390 |
| 2023-05-18 | Bode John B Director | Purchase | +300 | $5.04 | $2K | 1,690 |
| 2023-05-18 | Bode John B Director | Purchase | +1,000 | $5.04 | $5K | 2,690 |
| 2023-05-18 | Bode John B Director | Purchase | +4,759 | $5.04 | $24K | 7,449 |
Page 7 of 9 · 166 trades